168 related articles for article (PubMed ID: 32374905)
1. In Celiac Disease Patients the In Vivo Challenge with the Diploid Triticum monococcum Elicits a Reduced Immune Response Compared to Hexaploid Wheat.
Picascia S; Camarca A; Malamisura M; Mandile R; Galatola M; Cielo D; Gazza L; Mamone G; Auricchio S; Troncone R; Greco L; Auricchio R; Gianfrani C
Mol Nutr Food Res; 2020 Jun; 64(11):e1901032. PubMed ID: 32374905
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity of monococcum wheat in celiac patients.
Gianfrani C; Maglio M; Rotondi Aufiero V; Camarca A; Vocca I; Iaquinto G; Giardullo N; Pogna N; Troncone R; Auricchio S; Mazzarella G
Am J Clin Nutr; 2012 Dec; 96(6):1339-45. PubMed ID: 23134879
[TBL] [Abstract][Full Text] [Related]
3. Triticum monococcum amylase trypsin inhibitors possess a reduced potential to elicit innate immune response in celiac patients compared to Triticum aestivum.
Iacomino G; Rotondi Aufiero V; Di Stasio L; Picascia S; Iannaccone N; Giardullo N; Troncone R; Gianfrani C; Mamone G; Mazzarella G
Food Res Int; 2021 Jul; 145():110386. PubMed ID: 34112389
[TBL] [Abstract][Full Text] [Related]
4. Oral Consumption of Bread from an RNAi Wheat Line with Strongly Silenced Gliadins Elicits No Immunogenic Response in a Pilot Study with Celiac Disease Patients.
Guzmán-López MH; Sánchez-León S; Marín-Sanz M; Comino I; Segura V; Vaquero L; Rivero-Lezcano OM; Pastor J; Sousa C; Vivas S; Barro F
Nutrients; 2021 Dec; 13(12):. PubMed ID: 34960101
[TBL] [Abstract][Full Text] [Related]
5. Extensive in vitro gastrointestinal digestion markedly reduces the immune-toxicity of Triticum monococcum wheat: implication for celiac disease.
Gianfrani C; Camarca A; Mazzarella G; Di Stasio L; Giardullo N; Ferranti P; Picariello G; Rotondi Aufiero V; Picascia S; Troncone R; Pogna N; Auricchio S; Mamone G
Mol Nutr Food Res; 2015 Sep; 59(9):1844-54. PubMed ID: 26016626
[TBL] [Abstract][Full Text] [Related]
6. Comparative Analysis of
Di Stasio L; Picascia S; Auricchio R; Vitale S; Gazza L; Picariello G; Gianfrani C; Mamone G
Front Nutr; 2020; 7():56. PubMed ID: 32671087
[TBL] [Abstract][Full Text] [Related]
7. Natural variation in toxicity of wheat: potential for selection of nontoxic varieties for celiac disease patients.
Spaenij-Dekking L; Kooy-Winkelaar Y; van Veelen P; Drijfhout JW; Jonker H; van Soest L; Smulders MJ; Bosch D; Gilissen LJ; Koning F
Gastroenterology; 2005 Sep; 129(3):797-806. PubMed ID: 16143119
[TBL] [Abstract][Full Text] [Related]
8. Antagonists and non-toxic variants of the dominant wheat gliadin T cell epitope in coeliac disease.
Anderson RP; van Heel DA; Tye-Din JA; Jewell DP; Hill AV
Gut; 2006 Apr; 55(4):485-91. PubMed ID: 16299041
[TBL] [Abstract][Full Text] [Related]
9. Lack of intestinal mucosal toxicity of Triticum monococcum in celiac disease patients.
Pizzuti D; Buda A; D'Odorico A; D'Incà R; Chiarelli S; Curioni A; Martines D
Scand J Gastroenterol; 2006 Nov; 41(11):1305-11. PubMed ID: 17060124
[TBL] [Abstract][Full Text] [Related]
10. Diversification of the celiac disease α-gliadin complex in wheat: a 33-mer peptide with six overlapping epitopes, evolved following polyploidization.
Ozuna CV; Iehisa JC; Giménez MJ; Alvarez JB; Sousa C; Barro F
Plant J; 2015 Jun; 82(5):794-805. PubMed ID: 25864460
[TBL] [Abstract][Full Text] [Related]
11. Mucosal cytokine response after short-term gluten challenge in celiac disease and non-celiac gluten sensitivity.
Brottveit M; Beitnes AC; Tollefsen S; Bratlie JE; Jahnsen FL; Johansen FE; Sollid LM; Lundin KE
Am J Gastroenterol; 2013 May; 108(5):842-50. PubMed ID: 23588237
[TBL] [Abstract][Full Text] [Related]
12. Intestinal T cell responses to gluten peptides are largely heterogeneous: implications for a peptide-based therapy in celiac disease.
Camarca A; Anderson RP; Mamone G; Fierro O; Facchiano A; Costantini S; Zanzi D; Sidney J; Auricchio S; Sette A; Troncone R; Gianfrani C
J Immunol; 2009 Apr; 182(7):4158-66. PubMed ID: 19299713
[TBL] [Abstract][Full Text] [Related]
13. Short wheat challenge is a reproducible in-vivo assay to detect immune response to gluten.
Camarca A; Radano G; Di Mase R; Terrone G; Maurano F; Auricchio S; Troncone R; Greco L; Gianfrani C
Clin Exp Immunol; 2012 Aug; 169(2):129-36. PubMed ID: 22774987
[TBL] [Abstract][Full Text] [Related]
14. Triticum monococcum in patients with celiac disease: a phase II open study on safety of prolonged daily administration.
Zanini B; Villanacci V; De Leo L; Lanzini A
Eur J Nutr; 2015 Sep; 54(6):1027-9. PubMed ID: 25840666
[TBL] [Abstract][Full Text] [Related]
15. Gliadin-Specific T-Cells Mobilized in the Peripheral Blood of Coeliac Patients by Short Oral Gluten Challenge: Clinical Applications.
Picascia S; Mandile R; Auricchio R; Troncone R; Gianfrani C
Nutrients; 2015 Dec; 7(12):10020-31. PubMed ID: 26633487
[TBL] [Abstract][Full Text] [Related]
16. A catalogue of Triticum monococcum genes encoding toxic and immunogenic peptides for celiac disease patients.
Vaccino P; Becker HA; Brandolini A; Salamini F; Kilian B
Mol Genet Genomics; 2009 Mar; 281(3):289-300. PubMed ID: 19104838
[TBL] [Abstract][Full Text] [Related]
17. Lack of immunogenicity of hydrolysed wheat flour in patients with coeliac disease after a short-term oral challenge.
Mandile R; Picascia S; Parrella C; Camarca A; Gobbetti M; Greco L; Troncone R; Gianfrani C; Auricchio R
Aliment Pharmacol Ther; 2017 Aug; 46(4):440-446. PubMed ID: 28627070
[TBL] [Abstract][Full Text] [Related]
18. Celiac disease T-cell epitopes from gamma-gliadins: immunoreactivity depends on the genome of origin, transcript frequency, and flanking protein variation.
Salentijn EM; Mitea DC; Goryunova SV; van der Meer IM; Padioleau I; Gilissen LJ; Koning F; Smulders MJ
BMC Genomics; 2012 Jun; 13():277. PubMed ID: 22726570
[TBL] [Abstract][Full Text] [Related]
19. Two prolamin peptides from durum wheat preclude celiac disease-specific T cell activation by gluten proteins.
De Vincenzi M; Vincentini O; Di Nardo G; Boirivant M; Gazza L; Pogna N
Eur J Nutr; 2010 Jun; 49(4):251-5. PubMed ID: 19894071
[TBL] [Abstract][Full Text] [Related]
20. Whole blood interleukin-2 release test to detect and characterize rare circulating gluten-specific T cell responses in coeliac disease.
Anderson RP; Goel G; Hardy MY; Russell AK; Wang S; Szymczak E; Zhang R; Goldstein KE; Neff K; Truitt KE; Williams LJ; Dzuris JL; Tye-Din JA
Clin Exp Immunol; 2021 Jun; 204(3):321-334. PubMed ID: 33469922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
